IN THE NEWS | XenoTherapeutics | United States

XENO FOUNDATION BOLD-01.png

XenoTherapeutics

In the News

Press Releases

October 15, 2020

XenoTherapeutics Granted U.S. Patent Covering Method of Producing Clinically Acceptable Porcine Cells, Tissues, and Organs for Human Xenotransplantation

December 19, 2019

Boston’s XenoTherapeutics Prepares to Donate Xeno-Skin™ to Burn Victims of New Zealand White Island Volcano Tragedy

April 4, 2019

XenoTherapeutics Wins ABA’s Best Bioengineering Paper Award for Research on Xeno-Skin™, a Novel Xenotransplantation Treatment for Severe Burns

December 07, 2018

XenoTherapeutics to Start First Human Trial of Xeno-Skin™, a Novel Xenotransplantation Treatment for Severe Burns

October 23, 2018

XenoTherapeutics Executives Spearhead Initial Hurricane Michael Relief Efforts in Panama City, Florida

October 05, 2018

XenoTherapeutics Presents Update on First Non-Human Transplant Technology

Recent Articles

Using animal organs in humans: 'It's just a question of when'

XenoTherapeutics to Start First Human Trial of Xeno-Skin™, a Novel Xenotransplantation Treatment for Severe Burns

XenoTherapeutics Plans to Initiate Clinical Trials for a Pig-Skin Burn Treatment

Losing the Humanity of Transplants

Boston startup to launch first trial of pig organ transplants in humans

FDA clears first xenotransplantation trial of skin cells derived from genetically engineered pigs

A nonprofit biotech venture is betting on pig skin to help burn victims with first-ever clinical trial

A groundbreaking ‘biologic Band-Aid’

On the Air

Paul Holzer, Interim CEO of XenoTherapeutics, Inc., On the Air with WBUR’s Sara-Rose Brenner